OSE Immunotherapeutics SA (LON:0RAD)
London · Delayed Price · Currency is GBP · Price in EUR 5.43
-0.07 (-1.31%)
At close: Nov 6, 2025
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of 105.1 million as of November 7, 2025. Its market cap has decreased by -41.73% in one year.
Market Cap
105.10M
Enterprise Value
93.68M
Revenue
69.00M
Ranking
n/a
PE Ratio
3.39
Stock Price
5.43
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 76.24M to 105.10M, an increase of 37.85%. That is a compound annual growth rate of 3.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 105.69M | -18.51% |
| Dec 31, 2024 | 129.69M | 85.55% |
| Dec 29, 2023 | 69.90M | -36.14% |
| Dec 30, 2022 | 109.46M | -30.57% |
| Dec 31, 2021 | 157.65M | 36.38% |
| Dec 31, 2020 | 115.60M | 147.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 199.02B |
| HSBC Holdings | 186.96B |
| Shell | 164.68B |
| Unilever | 114.35B |
| Rolls-Royce Holdings | 94.84B |
| British American Tobacco p.l.c. | 90.53B |
| Rio Tinto Group | 89.87B |
| GSK plc | 71.49B |